Add Yahoo as a preferred source to see more of our stories on Google. President Donald Trump’s approach to lowering drug prices has leaned heavily on executive orders and voluntary deals with ...

On May 12, 2025, the Centers for Medicare & Medicaid Services (CMS) issued draft guidance for the third cycle of the IRA’s Medicare Drug Price Negotiation Program (Negotiation Program). This draft ...

The third round of the Medicare Drug Price Negotiation Program is moving forward with full manufacturer participation. The program, created under the Inflation Reduction Act, allows CMS to directly ...

This article is the latest in the Health Affairs Forefront featured topic, “Health Policy at a Crossroads,” produced with the support of the Commonwealth Fund and the Robert Wood Johnson Foundation.

As President Donald Trump touts new deals to cut the cost of blockbuster drugs like Wegovy and Zepbound, he’s barely mentioned Medicare’s drug price negotiation program — even though the government is ...